Insider Transactions Reported by 16 Insiders of Deciphera Pharmaceuticals, Inc.

Location
Waltham, MA

There are no Buy or Sell transactions made by insiders since 09 Jan 2025

Deciphera Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brightstar Associates LLC 10%+ Owner $360,891,375 22 Apr 2024
Daniel Lee Flynn Chief Scientific Officer $6,175,527 16 Jun 2023
James Arthur Bristol Director $0 11 Jun 2024
Dashyant Dhanak EVP & Chief Scientific Officer $0 11 Jun 2024
Matthew L. Sherman EVP & Chief Medical Officer $0 11 Jun 2024
Patricia L. Allen Director $0 11 Jun 2024
Susan L. Kelley Director $0 11 Jun 2024
Daniel C. Martin Chief Commercial Officer $0 11 Jun 2024
Steven L. Hoerter President and CEO, Director $0 11 Jun 2024
Ron Squarer Director $0 11 Jun 2024
Edward J. Benz JR Director $0 11 Jun 2024
John Richard Martin Director $0 11 Jun 2024
Franklin Stuart Friedman Director $0 11 Jun 2024
Dennis Leo Walsh Director $0 11 Jun 2024
Thomas Patrick Kelly Chief Financial Officer $0 11 Jun 2024
Jama Pitman SVP, Chief Development Officer $0 11 Jun 2024

Recent Insider Transactions by Companies or Individuals for Deciphera Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.